featured news
Free Weekly Newsletter.
We've been publishing our newsletter since 1998, and have had our share of huge winners including Immunomedics (IMMU) $3.00 to $86.00 (2016-2020). So sign up, it's free, and see what else we can come up with!
ALL NEWS
Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process.
Lightly traded (400,000 today) we were...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude.
We...
Alzheimer Drug Trials
A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022
Eli Lilly CEO David Ricks was confident last year that donanemab...
YIKES! New Form of Antimicrobial Resistance Discovered – One of the World’s Greatest Health...
A new mechanism has been discovered that enables bacteria to take up nutrients from their human host and bypass antibiotic treatment. This new form of antimicrobial resistance is undetectable using traditional laboratory...
Silo Pharma (SILO) Issues Letter to Shareholders
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
LIVE QUOTE
Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
New Report Coming, Sign up to our Newsletter for Priority Notification.
Absolutely banging numbers, we view Smart for Life (SMFL) as a company which doesn't have competition,...
Smart for Life (SMFL) Reports, Headlines and More.
Smart For Life Corporate Investor Center
2022, 28-11. ($0.40) Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
2022, 10-21....
Iconic Brands (ICNB). Liked it at $0.20, Love it at $0.09.
With Upcoming 9 Month Revenues Expected to be 3X Last Years Revenues, Still one of our Favorites.
LIVE QUOTE
We’d like...
Provention Bio (PRVB) Gains 26% Last Week.
We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm Down, Let's see how This Plays Out!
FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).
Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a one-time treatment.
FDA approves most expensive...
FDA Approval for Provention Bio (PRVB).
Re-cork the Champagne!
We were contemplating (dreaming) about an opening price over $12, and then a drift up towards $20, sometime during 2023. But no, it trades down...
Provention Biosciences (PRVB) Enters the Danger Zone.
Chart Looks Beautiful - But Nervous is why, we use soft and dry.
LIVE QUOTE
We'll be short and sweet. We make no prediction as for...
Progressive Care (RXMD) Conference Call.
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
MIAMI, FL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD), a...
DCS (DCSX) and Cellcom Enhance Partnership for IoT Solutions
LIVE QUOTE
San Diego, California--(Newsfile Corp. - November 14, 2022) - Direct Communication Solutions, Inc. (OTCQX: DCSX) (CSE: DCSI) (FSE: 7QU) a leading provider of information...
Progressive Care Launches Native Remote Patient Monitoring Mobile App .
Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care
MIAMI, FL, Nov. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
New Report Coming, Sign up to our Newsletter for Priority Notification.
Absolutely banging numbers, we view Smart for Life (SMFL) as a company which doesn't have competition,...
Smart for Life (SMFL) Reports, Headlines and More.
Smart For Life Corporate Investor Center
2022, 28-11. ($0.40) Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
2022, 10-21....
Progressive Care (RXMD) Conference Call.
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
MIAMI, FL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD), a...
DCS (DCSX) and Cellcom Enhance Partnership for IoT Solutions
LIVE QUOTE
San Diego, California--(Newsfile Corp. - November 14, 2022) - Direct Communication Solutions, Inc. (OTCQX: DCSX) (CSE: DCSI) (FSE: 7QU) a leading provider of information...
It’s 2:00AM, Do You Know Where Your Fleet of $1,400 E-Bikes are Parked? DCSX
DCS (DCSX) Announces the Launch of MiEbike: a Cloud-Based Asset Tracking Solution for the Growing E-Bike Market
San Diego, California--(Newsfile Corp. - October 31, 2022) - Direct Communication...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided...
Silo Pharma (SILO) Issues Letter to Shareholders
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
LIVE...
Provention Bio (PRVB) Gains 26% Last Week.
We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm...
FDA Approves Most Expensive Drug Ever, @ $3.5 Million-Per-Dose, from uniQure (QURE).
Important to note, the FDA didn't approve the price, they approved the drug. It was priced afterwards. Second item it is a...
FDA Approval for Provention Bio (PRVB).
Re-cork the Champagne!
We were contemplating (dreaming) about an opening price over $12, and then a drift up...
IPOS
conference calls
Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?
Adding Nautilus to the Watch List. Conference Call Transcript Below
New Street Targets at $15 per Share.
Latest article
Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided...
Alzheimer Drug Trials
A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022
Eli...
Most popular
And We Have Our First MEME Stock! $2.00 to $29.95.
Tiny U.S. Biotech Jumps 930% as It Picks Up Retail Attention (Bloomberg)
Guess we were bound to stumble across...
Revive Therapeutics (RVVTF) Provides Update of Psilocybin Pharmaceutical Programs
IRB approval to initiate Phase 2 study for methamphetamine abuse disordersAdvancing psilocybin oral thin film, microneedle patch and biosynthesis programs
Travel Technology: Marriott to Open 1,700 Hotels in Three Years. Conference Call.
Marriott Bonvoy Reached 125 Million Members.
Marriott International Announces Three-Year Growth Plan
Growth Model...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
LATEST ARTICLES
Latest article
Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.
After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided...
Alzheimer Drug Trials
A winner is crowned in head-to-head Alzheimer's battle between Biogen's Aduhelm and Lilly - Dec 1, 2022
Eli...
